These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
490 related items for PubMed ID: 17664320
1. influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene. Torrico M, Aguilar L, González N, Giménez MJ, Echeverría O, Cafini F, Sevillano D, Alou L, Coronel P, Prieto J. Antimicrob Agents Chemother; 2007 Oct; 51(10):3699-706. PubMed ID: 17664320 [Abstract] [Full Text] [Related]
2. Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different {beta}-lactams: an in vitro pharmacodynamic approach. González N, Aguilar L, Alou L, Giménez MJ, Sevillano D, Torrico M, Cafini F, Coronel P, Prieto J. J Antimicrob Chemother; 2009 Jun; 63(6):1215-22. PubMed ID: 19307171 [Abstract] [Full Text] [Related]
3. Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view? Alou L, Giménez MJ, Sevillano D, Aguilar L, González N, Echeverría O, Torrico M, Coronel P, Prieto J. J Antimicrob Chemother; 2007 Apr; 59(4):652-7. PubMed ID: 17341471 [Abstract] [Full Text] [Related]
4. Efficacy of simulated cefditoren versus amoxicillin-clavulanate free concentrations in countering intrastrain ftsI gene diffusion in Haemophilus influenzae. González N, Aguilar L, Sevillano D, Giménez MJ, Alou L, Cafini F, Torrico M, López AM, Coronel P, Prieto J. Antimicrob Agents Chemother; 2011 Jun; 55(6):2788-94. PubMed ID: 21464255 [Abstract] [Full Text] [Related]
5. Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in beta-lactamase-positive, amoxicillin/clavulanate-resistant Haemophilus influenzae. Matic V, Bozdogan B, Jacobs MR, Ubukata K, Appelbaum PC. J Antimicrob Chemother; 2003 Dec; 52(6):1018-21. PubMed ID: 14585854 [Abstract] [Full Text] [Related]
6. High prevalence of type b beta-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced. Hasegawa K, Kobayashi R, Takada E, Ono A, Chiba N, Morozumi M, Iwata S, Sunakawa K, Ubukata K, Nationwide Surveillance for Bacterial Meningitis. J Antimicrob Chemother; 2006 Jun; 57(6):1077-82. PubMed ID: 16617062 [Abstract] [Full Text] [Related]
7. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China. Yang Q, Xu Y, Chen M, Wang H, Sun H, Hu Y, Zhang R, Duan Q, Zhuo C, Cao B, Liu Y, Yu Y, Sun Z, Chu Y. Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692 [Abstract] [Full Text] [Related]
8. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. Fenoll A, Aguilar L, Robledo O, Giménez MJ, Tarragó D, Granizo JJ, Gimeno M, Coronel P. J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681 [Abstract] [Full Text] [Related]
9. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain. Seral C, Suárez L, Rubio-Calvo C, Gómez-Lus R, Gimeno M, Coronel P, Durán E, Becerril R, Oca M, Castillo FJ. Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733 [Abstract] [Full Text] [Related]
10. Polymorphism in ftsI gene and {beta}-lactam susceptibility in Portuguese Haemophilus influenzae strains: clonal dissemination of beta-lactamase-positive isolates with decreased susceptibility to amoxicillin/clavulanic acid. Barbosa AR, Giufrè M, Cerquetti M, Bajanca-Lavado MP. J Antimicrob Chemother; 2011 Apr; 66(4):788-96. PubMed ID: 21393206 [Abstract] [Full Text] [Related]
11. Comparative bacteriological efficacy of pharmacokinetically enhanced amoxicillin-clavulanate against Streptococcus pneumoniae with elevated amoxicillin MICs and Haemophilus influenzae. Berry V, Hoover J, Singley C, Woodnutt G. Antimicrob Agents Chemother; 2005 Mar; 49(3):908-15. PubMed ID: 15728883 [Abstract] [Full Text] [Related]
12. Genetic diversity of the ftsI gene in β-lactamase-nonproducing ampicillin-resistant and β-lactamase-producing amoxicillin-/clavulanic acid-resistant nasopharyngeal Haemophilus influenzae strains isolated from children in South Korea. Park C, Kim KH, Shin NY, Byun JH, Kwon EY, Lee JW, Kwon HJ, Choi EY, Lee DG, Sohn WY, Kang JH. Microb Drug Resist; 2013 Jun; 19(3):224-30. PubMed ID: 23308379 [Abstract] [Full Text] [Related]
13. Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea. Kim IS, Ki CS, Kim S, Oh WS, Peck KR, Song JH, Lee K, Lee NY. Antimicrob Agents Chemother; 2007 Feb; 51(2):453-60. PubMed ID: 17116681 [Abstract] [Full Text] [Related]
14. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis? Pottumarthy S, Sader HS, Fritsche TR, Jones RN. Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168 [Abstract] [Full Text] [Related]
15. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000. Koeth LM, Jacobs MR, Good CE, Bajaksouzian S, Windau A, Jakielaszek C, Saunders KA. Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258 [Abstract] [Full Text] [Related]
16. Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolone resistance-determining regions. Hirakata Y, Ohmori K, Mikuriya M, Saika T, Matsuzaki K, Hasegawa M, Hatta M, Yamamoto N, Kunishima H, Yano H, Kitagawa M, Arai K, Kawakami K, Kobayashi I, Jones RN, Kohno S, Yamaguchi K, Kaku M. Antimicrob Agents Chemother; 2009 Oct; 53(10):4225-30. PubMed ID: 19651910 [Abstract] [Full Text] [Related]
17. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis. Bogdanovich T, Clark C, Ednie L, Lin G, Smith K, Shapiro S, Appelbaum PC. Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565 [Abstract] [Full Text] [Related]
18. [Sensitivity surveillance of Haemophilus influenzae isolates for several antibiotics in Gifu Prefecture (2006)]. Working Group of Tokai Anti-biogram Study GroupResearch Laboratories of Toyama Chemical Co., Ltd., Kaeriyama M, Mizunaga S, Mitsuyama J, Yamaoka K, Asano Y, Sawamura H, Suematsu H, Teraji M, Tsuchiya M, Hashido H, Matsukawa Y, Matsubara S, Miyabe T, Watanabe K, Mikamo H. Jpn J Antibiot; 2008 Aug; 61(4):195-208. PubMed ID: 19024643 [Abstract] [Full Text] [Related]